Guru Ownership Trend
Guru Analysis for AnaptysBio, Inc. (ANAB)
AnaptysBio, Inc. (ANAB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6.97 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 303.5%. Conversely, Joel Greenblatt reduced exposure by 55.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for AnaptysBio, Inc. (ANAB)
Major holders include Renaissance Technologies (RenTech) ($3.94 M), Cliff Asness ($3.13 M), John Hussman ($1.42 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 151,934 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6.97 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited ANAB. The total reported sell value was $8.92 M.
Yes, 0 managers opened new positions in ANAB, and 2 increased their existing holdings. The total reported buy value was $1.95 M.